Articles tagged "Liver transplantation"

2018 American Transplant Congress
Validating MORAL in Living Donor Liver Transplantation for Hepatocellular Carcinoma
A. Bhatti, A. Qureshi, N. Khan, M. Butt, A. Waheed, A. Rana, F. Dar.
Hepatobiliary Surgery and Liver Transplantation, Hepatology, Radiology, Shifa International Hospital, Islamabad, Pakistan.
The “Model of Recurrence after Liver Transplant” (MORAL) study has identified certain pre and post operative variables that have significant impact on recurrence free survival…
2018 American Transplant Congress
Cost Analysis of Biliary Strictures Following Orthotopic Liver Transplantation in the United States
J. Jones,¹ N. Bhutiani,¹ D. Wei,² L. Goldstein,³ R. Martin,¹ C. Jones,¹ R. Cannon.¹
¹Surgery, University of Louisville, Louisville, KY; ²Real-world Data Analytics and Research, Johnson & Johnson, New Brunswick, NJ; ³Health Economics and Market Access, Ethicon, Inc., Somerville, NJ.
Introduction: While previous studies have evaluated risk factors, management, and outcomes in patients who develop biliary strictures (BS) after undergoing orthotopic liver transplantation (OLT), none…
2018 American Transplant Congress
The Impact of Spontaneous Bacterial Peritonitis on Patient Outcomes after Liver Transplantation Using the Scientific Registry of Transplant Recipient (SRTR) Database
D. Moonka,¹ G. Divine,² S. Nagai.³
¹Division of Gastroenterology and Hepatology, Henry Ford Health System, Detroit, MI; ²Public Health Sciences, Henry Ford Health System, Detroit, MI; ³Transplant Institute, Henry Ford Health System, Detroit, MI.
Spontaneous bacterial peritonitis (SBP) is associated with abdominal inflammation and increased morbidity in patients with end-stage liver disease. However, SBP has generally not been associated…
2018 American Transplant Congress
Frailty and Liver Transplantation
C. Haugen, H. Ying, C. Holscher, J. Lai, J. Garonzik-Wang, M. McAdams-DeMarco, D. Segev.
Surgery, JHU, Baltimore.
Frailty is a phenotype of decreased physiologic reserve in response to stressors. Fried frailty was developed in community dwelling older adults. Among LT waitlist patients,…
2018 American Transplant Congress
Bacterial Complications in Liver Transplant Recipients Undergoing Biliary Tract Manipulation: Effect of an Antibiotic Prophylaxis Protocol
C. Clifford, N. Theodoropoulos, J. Daly, L. Gibson, S. Mehta, H. Malik, A. Bozorgzadeh.
University of Massachusetts Medical School, Worcester, MA.
Purpose: The purpose of this study was to evaluate incidence of bacteremia and outcomes in liver transplant recipients that had biliary tract manipulation before and…
2018 American Transplant Congress
Kidney and Liver DCD Outcomes – A Five Year Review
J. Buggs,¹ J. Boone,² M. Adesunkanmi,² R. Mehta,² E. Rogers,³ A. Kumar,⁴ A. Alsina,¹ V. Bowers.¹
¹Transplant Surgery, Tampa General Medical Group, Tampa General Hospital, Tampa, FL; ²Pre-Med Undergraduate, University of South Florida, Tampa, FL; ³Transplant Research, Tampa General Hospital, Tampa, FL; ⁴Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL.
Background: The demand for organ transplantation exceeds the supply and has led to an increase in use of donation after cardiac death (DCD) solid organs…
2018 American Transplant Congress
Living Donor Liver Transplant (LDLT) at a Single Center- Intraoperative Technical Modifications and Optimization of Flow Dynamics to Improve Outcomes
A. Humar, S. Ganesh, A. Tevar, M. Molinari, C. Hughes.
Surgery, University of Pittsburgh, Pittsburgh.
Objectives: While LDLT represents the dominant method of LTx in the East, it remains an underutilized procedure in the US, accounting for <5% of all…
2018 American Transplant Congress
Hepatitis C Recurrence after Liver Transplant: A Comparison of Antibody Induction versus No Antibody Induction
S. Patel, J. Jin, E. Benedetti, P. West-Thielke.
University of Illinois Hospital and Health Sciences System, Chicago.
Background: Hepatitis C virus (HCV) recurrence after orthotopic liver transplant (OLT) is universal and exhibits accelerated progression to cirrhosis. Progression can be mitigated by new…
2018 American Transplant Congress
Complex Combined Thoracic/liver Transplant: A Seven Year Experience
N. Presser, J. DiNorcia, V. Agopian, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.
Liver and Pancreas Transplant, UCLA, Los Angeles, CA.
Background: While rare, combined Thoracic/Liver transplants are employed with increasing frequency. Consistent data regarding the technical conduct, patient selection and outcomes in this highly complex…
2018 American Transplant Congress
The Impact of Donor Specific Alloantibodies on Long-Term Outcomes of Liver Re-Transplantation
Q. Xu,¹ A. Skaro,² V. McAlister.²
¹Department of Pathology and Lab Medicine, University of Western Ontario, London, ON, Canada; ²Department of Surgery, University of Western Ontario, London, ON, Canada.
Despite reports that associate donor specific antibody (DSA) with rejection after liver transplantation, grafts are still allocated according to blood group (ABO) but not human…